Sequenom Overview
- Year Founded
-
1994
- Status
-
Acquired/Merged
- Employees
-
434
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$379M
Sequenom General Information
Description
Provider of genetic analysis products and diagnostic tests for non-invasive prenatal genetic disorders. The company provides nucleic acid analysis platform that measures genetic target material and variations.
Contact Information
Website
www.sequenom.comCorporate Office
- 3595 John Hopkins Court
- San Diego, CA 92121
- United States
Corporate Office
- 3595 John Hopkins Court
- San Diego, CA 92121
- United States
Sequenom Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 18. Merger/Acquisition | 07-Sep-2016 | $379M | Completed | Generating Revenue | ||
| 17. Debt Refinancing | 18-Jun-2015 | Completed | Generating Revenue | |||
| 16. Debt - General | 20-Sep-2012 | Completed | Generating Revenue | |||
| 15. 2PO | 25-Jan-2012 | Completed | Generating Revenue | |||
| 14. Debt - General | 02-Jun-2011 | Completed | Generating Revenue | |||
| 13. PIPE | 21-May-2010 | Completed | Generating Revenue | |||
| 12. PIPE | 23-Dec-2009 | Completed | Generating Revenue | |||
| 11. PIPE | 09-Mar-2009 | Completed | Generating Revenue | |||
| 10. PIPE | 19-Nov-2008 | $3.6M | $247M | Completed | Generating Revenue | |
| 9. Secondary Transaction - Open Market | 01-Aug-2008 | $244M | Completed | Generating Revenue |
Sequenom Comparisons
Industry
Financing
Details
Sequenom Competitors (3)
One of Sequenom’s 3 competitors is OncoDNA, a Venture Capital-Backed company based in Gosselies, Belgium.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| OncoDNA | Venture Capital-Backed | Gosselies, Belgium | ||||
| Illumina | Formerly VC-backed | San Diego, CA | ||||
| Natera | Formerly VC-backed | Austin, TX |
Sequenom Patents
Sequenom Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3183597-A1 | Methods, systems, and compositions for the analysis of cell-free nucleic acids | Pending | 14-May-2020 | ||
| EP-4150074-A1 | Methods, systems, and compositions for the analysis of cell-free nucleic acids | Inactive | 14-May-2020 | ||
| US-20230220484-A1 | Methods, systems, and compositions for the analysis of cell-free nucleic acids | Inactive | 14-May-2020 | ||
| WO-2021231912-A1 | Methods, systems, and compositions for the analysis of cell-free nucleic acids | Inactive | 14-May-2020 | ||
| CA-3159786-A1 | Application of mosaicism ratio in multifetal gestations and personalized risk assessment | Pending | 31-Oct-2019 | G16B20/10 |
Sequenom Signals
Sequenom Former Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Delaware Crossing Investor Group | Angel Group | Minority | ||
| EQT Life Sciences | Venture Capital | Minority | ||
| Fort Mason Capital | PE/Buyout | Minority | ||
| Global Life Science Ventures | Venture Capital | Minority | ||
| Haspa BGM | PE/Buyout | Majority |
Sequenom Acquisitions (2)
Sequenom’s most recent deal was a Merger/Acquisition with SensiGen for . The deal was made on 27-Jan-2009.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| SensiGen | 27-Jan-2009 | Merger/Acquisition | Biotechnology | ||
| Sequenom Center for Molecular Medicine | 17-Nov-2008 | Merger/Acquisition | Laboratory Services (Healthcare) |
Sequenom FAQs
-
When was Sequenom founded?
Sequenom was founded in 1994.
-
Where is Sequenom headquartered?
Sequenom is headquartered in San Diego, CA.
-
What is the size of Sequenom?
Sequenom has 434 total employees.
-
What industry is Sequenom in?
Sequenom’s primary industry is Monitoring Equipment.
-
Is Sequenom a private or public company?
Sequenom is a Private company.
-
What is the current valuation of Sequenom?
The current valuation of Sequenom is .
-
What is Sequenom’s current revenue?
The current revenue for Sequenom is .
-
How much funding has Sequenom raised over time?
Sequenom has raised $524M.
-
Who are Sequenom’s investors?
Delaware Crossing Investor Group, EQT Life Sciences, Fort Mason Capital, Global Life Science Ventures, and Haspa BGM are 5 of 16 investors who have invested in Sequenom.
-
Who are Sequenom’s competitors?
-
When was Sequenom acquired?
Sequenom was acquired on 07-Sep-2016.
-
Who acquired Sequenom?
Sequenom was acquired by Labcorp Holdings.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process